Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317029,Aia19,Adjuvant induced arthritis QTL 19,2.98,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),10,69385595,112626471,Rat,n/a,region,qtl 1000,61325,Aia5,Adjuvant induced arthritis QTL 5,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,2317039,Aia6,Adjuvant induced arthritis QTL 6,4.31,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),10,69385595,112626471,Rat,n/a,region,qtl 1000,12880396,Am13,Aortic mass QTL 13,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),10,93662786,112626471,Rat,n/a,region,qtl 1000,1600376,Arunc5,Aerobic running capacity QTL 5,,0.21,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),3,78700444,123700444,Rat,n/a,region,qtl 1000,1578672,Bmd16,Bone mineral density QTL 16,6.2,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),10,100155035,110992275,Rat,n/a,region,qtl 1000,2300172,Bmd57,Bone mineral density QTL 57,9.8,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),10,73008136,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),10,53621375,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,53621375,112626471,Rat,n/a,region,qtl 1000,631649,Bp123,Blood pressure QTL 123,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,94788365,139788365,Rat,n/a,region,qtl 1000,724530,Bp149,Blood pressure QTL 149,,0.0001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,93886117,112626471,Rat,n/a,region,qtl 1000,1300137,Bp186,Blood pressure QTL 186,3.57,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),10,93886117,110992275,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1579915,Bp280,Blood pressure QTL 280,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,93662786,112626471,Rat,n/a,region,qtl 1000,1642980,Bp300,Blood pressure QTL 300,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,70800069,112626471,Rat,n/a,region,qtl 1000,2292436,Bp310,Blood pressure QTL 310,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,98079221,112626471,Rat,n/a,region,qtl 1000,2292438,Bp311,Blood pressure QTL 311,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,78970279,112626471,Rat,n/a,region,qtl 1000,10450493,Bp382,Blood pressure QTL 382,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,98079221,112626471,Rat,n/a,region,qtl 1000,10450498,Bp384,Blood pressure QTL 384,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,70166960,112626471,Rat,n/a,region,qtl 1000,61396,Bp9,Blood pressure QTL 9,4.8,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,71692298,112626471,Rat,n/a,region,qtl 1000,1578663,Bss18,Bone structure and strength QTL 18,3.6,,femur width (VT:1000666),femoral neck width (CMO:0001695),10,100155035,110992275,Rat,n/a,region,qtl 1000,2293646,Bss25,Bone structure and strength QTL 25,10.96,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293663,Bss33,Bone structure and strength QTL 33,9.34,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293698,Bss43,Bone structure and strength QTL 43,5.33,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),10,62096293,107096293,Rat,n/a,region,qtl 1000,2313105,Bss79,Bone structure and strength QTL 79,1.8,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),10,65992275,110992275,Rat,n/a,region,qtl 1000,2313103,Bss80,Bone structure and strength QTL 80,2,0.0001,tibia strength trait (VT:1000284),tibia midshaft endosteal cross-sectional area (CMO:0001716),10,65992275,110992275,Rat,n/a,region,qtl 1000,1354641,Bvd2,Brain ventricular dilatation QTL 2,6.36,0.001,brain ventricle morphology trait (VT:0000822),hydrocephalus severity score (CMO:0001881),10,96520816,110992275,Rat,n/a,region,qtl 1000,6893366,Bw106,Body weight QTL 106,0.3,0.47,body mass (VT:0001259),body weight (CMO:0000012),10,73467158,112626471,Rat,n/a,region,qtl 1000,7387306,Bw124,Body weight QTL 124,3.2,0.0003,body mass (VT:0001259),body weight (CMO:0000012),3,88910015,133910015,Rat,n/a,region,qtl 1000,7387312,Bw125,Body weight QTL 125,3,0.0047,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight (CMO:0000356),10,67880046,112626471,Rat,n/a,region,qtl 1000,8694437,Bw167,Body weight QTL 167,22.46,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),3,97009185,142009185,Rat,n/a,region,qtl 1000,12879848,Bw181,Body weght QTL 181,,0.015,body mass (VT:0001259),body weight (CMO:0000012),3,72672290,127023997,Rat,n/a,region,qtl 1000,1558652,Bw57,Body weight QTL 57,4.2,0.0008,body mass (VT:0001259),body weight (CMO:0000012),10,94170766,112626471,Rat,n/a,region,qtl 1000,1582219,Bw63,Body weight QTL 63,3.8,0.001,body mass (VT:0001259),body weight (CMO:0000012),3,100730984,119830094,Rat,n/a,region,qtl 1000,1582216,Bw65,Body weight QTL 65,6.3,,body mass (VT:0001259),body weight (CMO:0000012),3,106900427,119830094,Rat,n/a,region,qtl 1000,1582238,Bw68,Body weight QTL 68,3.2,0.0064,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582210,Bw71,Body weight QTL 71,3.3,0.0012,body mass (VT:0001259),body weight (CMO:0000012),3,66711607,119830094,Rat,n/a,region,qtl 1000,1582218,Bw74,Body weight QTL 74,3.9,0.0021,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,631665,Bw8,Body weight QTL 8,5.5,,body mass (VT:0001259),body weight (CMO:0000012),3,51821836,124513579,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2303589,Bw87,Body weight QTL 87,2,,body mass (VT:0001259),body weight (CMO:0000012),10,85079943,112626471,Rat,n/a,region,qtl 1000,2312670,Bw94,Body weight QTL 94,,0.01,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),3,103141814,176418101,Rat,n/a,region,qtl 1000,70171,Cari1,Carrageenan-induced inflammation QTL 1,4.9,0.0005,hypodermis integrity trait (VT:0010550),inflammatory exudate volume (CMO:0001429),10,55678976,112626471,Rat,n/a,region,qtl 1000,631267,Cia20,Collagen induced arthritis QTL 20,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14827894,107857673,Rat,n/a,region,qtl 1000,631269,Cia22,Collagen induced arthritis QTL 22,8.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,631270,Cia23,Collagen induced arthritis QTL 23,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,1302404,Cia27,Collagen induced arthritis QTL 27,2.6,0.0045,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),10,79927661,112626471,Rat,n/a,region,qtl 1000,1576307,Cia28,Collagen induced arthritis QTL 28,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,99492217,107857673,Rat,n/a,region,qtl 1000,61436,Cia5,Collagen induced arthritis QTL 5,4.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,94486204,107857673,Rat,n/a,region,qtl 1000,61449,Ciaa2,CIA Autoantibody QTL 2,7.1,,blood autoantibody amount (VT:0003725),calculated serum anti-type 2 collagen antibody titer (CMO:0001279),10,65590122,110590122,Rat,n/a,region,qtl 1000,12880384,Cm107,Cardiac mass QTL 107,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),,93662786,112626471,Rat,n/a,region,qtl 1000,12880385,Cm108,Cardiac mass QTL 108,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),,93662786,112626471,Rat,n/a,region,qtl 1000,12880395,Cm109,Cardiac mass QTL 109,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),10,93662786,112626471,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,724532,Cm17,Cardiac mass QTL 17,2,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),3,101058963,146058963,Rat,n/a,region,qtl 1000,1331791,Cm31,Cardiac mass QTL 31,3.84606,,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,23861015,112626471,Rat,n/a,region,qtl 1000,1581503,Cm58,Cardiac mass QTL 58,2.7,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,45406058,127023997,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,1354611,Despr2,Despair related QTL 2,3.03,0.0028,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),3,102466149,147466149,Rat,n/a,region,qtl 1000,1581559,Eae18,Experimental allergic encephalomyelitis QTL 18,,0.00002,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),10,67988218,110992091,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,1582239,Epfw1,Epididymal fat weight QTL 1,4.5,0.0006,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,119830094,Rat,n/a,region,qtl 1000,2292613,Ept16,Estrogen-induced pituitary tumorigenesis QTL 16,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1358186,Ept2,Estrogen-induced pituitary tumorigenesis QTL 2,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,2317754,Glom25,Glomerulus QTL 25,3.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,86566908,112626471,Rat,n/a,region,qtl 1000,2302273,Gluco35,Glucose level QTL 35,5.3,0.001,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,83817637,119509260,Rat,n/a,region,qtl 1000,2302373,Gluco39,Glucose level QTL 39,5.01,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),3,103141944,170934860,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14827894,110992275,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,30114912,123700444,Rat,n/a,region,qtl 1000,2293087,Iddm27,Insulin dependent diabetes mellitus QTL 27,2.68,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,102152812,155263151,Rat,n/a,region,qtl 1000,1582221,Kidm30,Kidney mass QTL 30,3.5,0.0008,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),3,66711607,119830094,Rat,n/a,region,qtl 1000,2301414,Kidm37,Kidney mass QTL 37,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,72973445,127023997,Rat,n/a,region,qtl 1000,12880398,Kidm67,Kidney mass QTL 67,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),10,93662786,112626471,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9841807,108540162,Rat,n/a,region,qtl 1000,1600367,Mcs15,Mammary carcinoma susceptibility QTL 15,4.5,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,88544136,107545372,Rat,n/a,region,qtl 1000,70193,Mcs7,Mammary carcinoma susceptibility QTL 7,2.38,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,75544754,112626471,Rat,n/a,region,qtl 1000,2298548,Neuinf7,Neuroinflammation QTL 7,3.4,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),10,75544754,112626471,Rat,n/a,region,qtl 1000,631841,Niddm39,Non-insulin dependent diabetes mellitus QTL 39,3.36,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,99465522,168732722,Rat,n/a,region,qtl 1000,634320,Niddm49,Non-insulin dependent diabetes mellitus QTL 49,4.41,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),10,91689348,112626471,Rat,n/a,region,qtl 1000,61363,Oia3,Oil induced arthritis QTL 3,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90296897,112626471,Rat,n/a,region,qtl 1000,631538,Oia5,Oil induced arthritis QTL 5,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90041957,112626471,Rat,n/a,region,qtl 1000,631539,Oia6,Oil induced arthritis QTL 6,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,100460820,108540162,Rat,n/a,region,qtl 1000,4889492,Pancm2,Pancreatic morphology QTL 2,3.2,,pancreatic beta cell morphology trait (VT:0005217),ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814),10,80239190,112626471,Rat,n/a,region,qtl 1000,61354,Pia10,Pristane induced arthritis QTL 10,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,1576313,Pia25,Pristane induced arthritis QTL 25,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,99492217,107857673,Rat,n/a,region,qtl 1000,1581546,Pur13,Proteinuria QTL 13,2.93,0.0335,total urine protein amount (VT:0000032),urine protein excretion rate (CMO:0000759),3,81136227,154416635,Rat,n/a,region,qtl 1000,1300111,Rf12,Renal function QTL 12,3.78,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),3,62922868,127023997,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,2312673,Scl63,Serum cholesterol level QTL 63,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,103141814,176418101,Rat,n/a,region,qtl 1000,2312659,Slep7,Serum leptin concentration QTL 7,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),3,103141814,176418101,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,1298078,Stresp5,Stress response QTL 5,2.99,0.00025,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,43289657,108540162,Rat,n/a,region,qtl 1000,724523,Tsu1,Thymus enlargement suppressive QTL 1,3.84,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),3,51822008,120917851,Rat,n/a,region,qtl 1000,8662816,Vetf4,Vascular elastic tissue fragility QTL 4,4,,renal artery integrity trait (VT:0010642),number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563),3,61241033,165369047,Rat,n/a,region,qtl